All

Results: 33409-33420 of 49016

Newmont's 2023 Sustainability Report (Graphic: Business Wire)

Newmont Publishes 2023 Sustainability Report and 2023 Tax & Royalties Report

Business Wire logo

Neil Waller and James Street Appointed Co-CEOs of Whalar Group

(Graphic: Business Wire)

Long Tale Games Relaunches Life is Feudal: MMO on Steam With a Significant Event, the Balance Restoration Campaign

PR Newswire associated0

PARIS RESTAURANT PLÉNITUDE IS REVEALED AS THE RECIPIENT OF THE ART OF HOSPITALITY AWARD 2024 BY THE WORLD'S 50 BEST RESTAURANTS

CoinEx Presents Beachside Soirée: Uniting Blockchain Industry Leaders and Influencers at Token 2049 Dubai

Business Wire logo

Vertex Announces Advancements of Suzetrigine (VX-548) in Acute and Neuropathic Pain

TriLink BioTechnologies® Cuts Ribbon on New San Diego Facility for Late Phase mRNA Drug Substance Production (Photo: TriLink BioTechnologies®)

TriLink BioTechnologies® Announces New San Diego Facility for Late Phase mRNA Drug Substance Production

Business Wire logo

Impact Disclosure Taskforce Releases Impact Disclosure Guidance, Helping Scale Financing for the UN Sustainable Development Goals

DeFi Technologies Subsidiary Valour Inc. Launches the First Short Spot Bitcoin ETP in the Nordics

A view of a soapbox called the ‘pelvic podium’ at Speakers Corner in Hyde Park, London, as part of a campaign to raise awareness of the UK’s maternal pelvic health crisis. Picture date: Thursday April 18, 2024. PA Photo. The campaign comes as women's health brand Elvie highlights that the Government’s deadline to introduce specialist perinatal pelvic health services across England has passed without meeting its target, finding that a third of the country is still without women's pelvic health services.

Activists Take To Pelvic Floor-Shaped Soapbox in Hyde Park to Raise Awareness of Women’s Pelvic Health Crisis

PR Newswire associated0

Univar Solutions European Customers Enjoy More Eco-Friendly Cereal Extract Options Through Expanded Partnership with Meurens Natural

Calliditas Therapeutics Presents Additional Data Analyses from the Phase 3 NeflgArd trial of Nefecon in Primary IgA Nephropathy at the ISN World Congress of Nephrology 2024